Search
Search Results
##search.searchResults.foundPlural##
-
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1290PDF: 809HTML: 10018cover letter to the editor: 146tile page: 234 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3300PDF: 1253HTML: 1845Fig.1: 179Fig. 2: 186 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3199PDF: 1307HTML: 2604 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2674PDF: 1740HTML: 3628Pellagatti Fig 1: 182Pellagatti Fig. 2: 182 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1231PDF: 428HTML: 377 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2484PDF: 795HTML: 14926Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 267 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1835PDF: 819HTML: 1246 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1488PDF: 944HTML: 150 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6656PDF: 3543HTML: 720 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
826PDF: 689HTML: 96 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1519PDF: 772HTML: 136 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
970PDF: 962HTML: 87 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1671PDF: 543HTML: 257







